Ningxia Qiyuan Pharmaceutical is an API manufacturer based in China. It holds 3 active US drug master files and 5 valid CEPs across a filed portfolio of 4 molecules. Its GMP standing is certified by EMA. Its most recent recorded inspection, by US FDA, closed on 28 June 2019 as VAI.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| Yingchuan, China | Not on file |
| China, China | 3004341367 |
| Yinchuan, China | Not on file |
| Yinchuan City, China | Not on file |
| Molecule | Regulators | Docs |
|---|---|---|
| Erythromycin | EDQM, US FDA | 4 |
| Tetracycline | EDQM, US FDA | 2 |
| Ascorbic Acid | EDQM | 1 |
| Azithromycin | EDQM | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| EMA | None | 1 |
Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.
Ask Fred what the record holds on Ningxia Qiyuan Pharmaceutical, including filings and inspection history.
Chat with Fred, your AI analystRanked by shared active ingredients where we have them, otherwise by country and comparable credentials.